Cosmo Pharmaceuticals N.V. provided earnings guidance for the year 2024 and revenue guidance for 2025. For the year, company is expecting operating profit and revenue to make a very meaningful jump. The company is figuring out a total revenue in the range of EUR 260 million to EUR 270 million, and an operating profit of EUR 155 million to EUR 165 million.

For the year 2025, company expects revenue objective for next year is going to be between EUR 240 million and EUR 260 million.